Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo (Q60933040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

main subject

molecular medicine

0 references

pharmaceutical science

0 references

author

Manfred Heller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Q64862675

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Matthias Miederer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

author name string

Tais Basaco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Stefanie Pektor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Josue M Bermudez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Niurka Meneses

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Kayluz F Boligán

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Stefan Schürch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Stephan von Gunten

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

Andreas Türler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

language of work or name

English

0 references

publication date

28 November 2018

0 references

published in

Pharmaceuticals

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

5 May 2020

page(s)

132

0 references

copyright license

start time

28 November 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6316122/fullTextXML

inferred from PubMed Central ID database lookup

cites work

N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates

1 reference

12 December 2020

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney

1 reference

12 December 2020

Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts

1 reference

12 December 2020

Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250

1 reference

12 December 2020

Radioimmunotherapy: recent results and future directions

1 reference

12 December 2020

Prevention of radiolysis of monoclonal antibody during labeling.

1 reference

12 December 2020

Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands

1 reference

12 December 2020

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

1 reference

12 December 2020

A strategy to reduce red marrow dose for intraperitoneal radioimmunotherapy

1 reference

12 December 2020

Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro.

1 reference

12 December 2020

Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts

1 reference

12 December 2020

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals

1 reference

12 December 2020

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

1 reference

12 December 2020

Targeted drug conjugates: principles and progress

1 reference

12 December 2020

Actinium-225 conjugates of MAb CC49 and humanized delta CH2CC49

1 reference

12 December 2020

In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications

1 reference

12 December 2020

Rituxan&#174; Immunotherapy and Zevalin&#174; Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

1 reference

12 December 2020

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re

1 reference

12 December 2020

Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis

1 reference

12 December 2020

Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma

1 reference

12 December 2020

The role of coordination chemistry in the development of target-specific radiopharmaceuticals

1 reference

12 December 2020

Perspectives on cancer therapy with radiolabeled monoclonal antibodies.

1 reference

12 December 2020

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

1 reference

12 December 2020

Development trends for monoclonal antibody cancer therapeutics.

1 reference

12 December 2020

Radiolabeled antibodies in renal cell carcinoma

1 reference

12 December 2020

Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6

1 reference

12 December 2020

Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides

1 reference

12 December 2020

Covalent modification of lysine residues by allyl isothiocyanate in physiological conditions: plausible transformation of isothiocyanate from thiol to amine.

1 reference

12 December 2020

Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

1 reference

12 December 2020

In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study

1 reference

12 December 2020

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

1 reference

12 December 2020

Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain

1 reference

12 December 2020

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

1 reference

12 December 2020

Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging

1 reference

12 December 2020

Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy

1 reference

12 December 2020

Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Proteome remodelling during development from blood to insect-form Trypanosoma brucei quantified by SILAC and mass spectrometry

1 reference

12 December 2020

Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma

1 reference

12 December 2020

Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells

1 reference

12 December 2020

DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl

1 reference

12 December 2020

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

1 reference

12 December 2020

A practical application of quantitative vascular image analysis in breast pathology

1 reference

12 December 2020

Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma

1 reference

12 December 2020

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

1 reference

12 December 2020

Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal [...]

1 reference

12 December 2020

Theranostic applications of antibodies in oncology.

1 reference

12 December 2020

Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model

1 reference

12 December 2020

The status of radioimmunotherapy in CD20 non-Hodgkin's lymphoma.

1 reference

12 December 2020

An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients

1 reference

12 December 2020

Selective chemical protein modification

1 reference

12 December 2020

Monoclonal antibody G250 targeting CA Ⅸ: Binding specificity, internalization and therapeutic effects in a non-renal cancer model

1 reference

12 December 2020

Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule

1 reference

12 December 2020

Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

1 reference

12 December 2020

Production of (177)Lu for Targeted Radionuclide Therapy: Available Options

1 reference

12 December 2020

Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

1 reference

12 December 2020

Antibody-drug conjugates--an emerging class of cancer treatment

1 reference

12 December 2020

A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.

1 reference

12 December 2020

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

1 reference

12 December 2020

Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts

1 reference

12 December 2020

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

1 reference

12 December 2020

Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen

1 reference

12 December 2020

Identifiers

DOI

10.3390/PH11040132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30487460 AND SRC:MED&resulttype=core&format=json

5 May 2020

PubMed publication ID

30487460

1 reference